thioridazine has been researched along with Metabolic Diseases in 2 studies
Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
VALLET, R | 1 |
Tyler, KL | 1 |
Tyler, HR | 1 |
2 other studies available for thioridazine and Metabolic Diseases
Article | Year |
---|---|
[TREATMENT OF PSYCHIC DISORDERS OF CEREBRAL ATHEROSCLEROSIS. DIAGNOSTIC, NOSOLOGIC AND PATHOGENIC ASPECTS].
Topics: Blood Glucose; Brain Ischemia; Cerebrovascular Circulation; Cholesterol; Dementia; Depression; Drug | 1964 |
Differentiating organic dementia.
Topics: Adult; Aged; Aging; Alzheimer Disease; Dementia; Diagnosis, Differential; Female; Humans; Male; Meta | 1984 |